Published • loading... • Updated
Stock Forecast: The Market is Sleeping on Eli Lilly's Next $1 Trillion Opportunity
The model cites 20% upside, 90% confidence and retatrutide as the main driver, with a bull case above $1,600 if the drug advances on schedule.
Summary by 24/7 Wall St.
2 Articles
2 Articles
Stock Forecast: The Market is Sleeping on Eli Lilly's Next $1 Trillion Opportunity
Eli Lilly just became the first pharmaceutical company ever valued above $1 trillion, yet analysts who dig into its pipeline are arguing the market still has not grasped what the next two years could look like for shareholders.
·Lakewood, United States
Read Full ArticleCoverage Details
Total News Sources2
Leaning Left1Leaning Right0Center1Last UpdatedBias Distribution50% Left, 50% Center
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
50% Center
L 50%
C 50%
Factuality
To view factuality data please Upgrade to Premium
